Clinical link between MHC class II haplotype and interferon-beta (IFN-β) immunogenicity
- 2 November 2005
- journal article
- Published by Elsevier BV in Clinical Immunology
- Vol. 118 (1), 42-50
- https://doi.org/10.1016/j.clim.2005.08.017
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Professional Antigen-Presentation Function by Human γδ T CellsScience, 2005
- Translating cell biology in vitro to immunity in vivoNature, 2004
- Immune recognition of a human renal cancer antigen through post-translational protein splicingNature, 2004
- The HLA-DR2 haplotype is associated with an increased proliferative response to the immunodominant CD4+ T-cell epitope in human interferon-βGenes & Immunity, 2004
- New HLA haplotype frequency reference standards: High‐resolution and large sample typing of HLA DR‐DQ haplotypes in a sample of European AmericansTissue Antigens, 2003
- Recombinant human thrombopoietin: basic biology and evaluation of clinical studiesBlood, 2002
- P575: HLA class II allele frequencies in unrelated donor bone marrow transplantationHuman Immunology, 1996
- Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell SrfacesInternational Immunology, 1990
- Polypeptide ligation occurs during post-translational modification of concanavalin ANature, 1985
- A General ANOVA Method for Robust Tests of Additive Models for VariancesJournal of the American Statistical Association, 1979